Notice of Results

Cambridge Cognition Holdings PLC

07 April 2026

 

7 April 2026

Cambridge Cognition Holdings plc

("Cambridge Cognition", the "Company" or the "Group")

Notice of Results

Cambridge Cognition Holdings plc (AIM: COG), the neuroscience technology company whose digital cognitive assessments drive scientific discovery, accelerate drug development and improve patient care will announce its results for the year ended 31 December 2025 on Monday 13 April 2026.

Enquiries:

Cambridge Cognition Holdings plc  Rob Baker, Chief Executive Officer Ronald Openshaw, Chief Financial Officer	Tel: [phone]  [e-mail]
Cavendish Capital Markets Limited (NOMAD and Joint Broker) Geoff Nash / Elysia Bough / Joe Smith Harriet Ward Nigel Birks	Tel: [phone] Corporate Finance Corporate Broking LS Specialist Sales
Singer Capital Markets Limited (Joint Broker)  Amber Higgs / James Serjeant / Daniel Ingram	Tel: [phone]

Notes to Editors

About Cambridge Cognition

Cambridge Cognition is a neuroscience technology company whose digital cognitive assessments drive scientific discovery, accelerate drug development and improve patient care.

Built on rich, curated data and deep technical expertise we are building a strong global brand with scalable technology that will support the rising world demand for diagnosing and treating brain health.  The Company creates shareholder value through organic sales growth, strategic partnerships, joint ventures, and spinouts.  The Company has identified four market sectors:

• Clinical Studies for new pharmaceuticals;
• Academic Research for scientists to understand CNS disorders;
• Healthcare to provide physicians with cognitive assessments to allow them to diagnose and treat patients; and,
• Consumer Health & Wellness to provide individuals access to accurate, reliable, and meaningful data to assess their cognitive health.

For further information, visit: www.cambridgecognition.com

 

END